Loading clinical trials...

COMPLETEDNA

Ultraslow Full-power SWL Versus Slow Power-ramping SWL in Stones With High Attenuation Value

NCT03763539•Cairo University

View on ClinicalTrials.gov

Summary

Ultraslow full-power SWL versus slow power-ramping SWL in stones with high attenuation value

Detailed Description

To evaluate the efficacy of ultraslow rate of SWL versus slow rate, power ramping SWL.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•single renal stone less than or equal to 3 cm (2 cm for lower calyceal stones)
•radio-opaque stone
•high attenuation value (≥ 1000 HU) stone

Exclusion Criteria

•Abnormal renal anatomy
•renal insufficiency
•solitary kidney
•coagulopathies
•uncontrolled hypertension
•renal artery or aortic aneurysm
•active urinary tract infection
•pregnancy
•severe skeletal malformations (spinal deformity) precluding proper stone localization
•skin to stone distance (SSD) \> 11 cm
+1 more criteria

Locations (1)

Beni-Suef Hospitals

Banī Suwayf, Outside U.S./Canada, Egypt

Key Dates

Start Date

September 1, 2015

Primary Completion Date

May 1, 2017

Completion Date

May 1, 2018

Last Updated

December 4, 2018

Enrollment

196

ACTUAL participants

Conditions

Renal Stones

Interventions

SWL

PROCEDURE

Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study

NCT07155005

UrolithiasisStones, Kidney+2 more

View study

NOT_YET_RECRUITINGNA

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

NCT07101809

UrolithiasisStones, Kidney+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Ultraslow Full-power SWL Versus Slow Power-ramping SWL in Stones With High Attenuation Value

Inclusion Criteria

Exclusion Criteria

Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT as Non-Invasive Modalities for Treating Small and Medium-Sized Radiolucent Renal Stones

Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation

Flexible Ureteroscopy With and Without Ureteral Access Sheath in Treatment of Large Renal Stones

to Study the Role of Retrograde Intrarenal Surgery in Management of Renal Stones